FOXP1 and non-small cell lung carcinoma: However, decreased FOXP1 protein expression in patients with solid tumors was associated with a significantly worse OS in most of the subgroup categories, and the worst OS was observed in NSCLC patients (HR = 3.11, 95%CI: 1.87–5.17, p < 0.001) (Table 5).